1. Home
  2. Analysis
  3. Detrol-la
  4. Stelazine

Detrol la and Stelazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Detrol la and Stelazine together.

The phase IV clinical study analyzes what interactions people who take Detrol la and Stelazine have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

2 people who take Detrol la and Stelazine together, and have interactions are studied.

What is Detrol la?

Detrol la has active ingredients of tolterodine tartrate. It is often used in urge incontinence. eHealthMe is studying from 13,128 Detrol la users for its effectiveness, alternative drugs and more.

What is Stelazine?

Stelazine has active ingredients of trifluoperazine hydrochloride. It is often used in schizophrenia. eHealthMe is studying from 1,304 Stelazine users for its effectiveness, alternative drugs and more.

Number of Detrol la and Stelazine reports submitted per year:

Detrol la and Stelazine drug interactions.

Common Detrol La and Stelazine drug interactions by gender *:

female:

  1. Diabetes mellitus
  2. Diabetic coma
  3. Diabetic ketoacidosis
  4. Extrapyramidal disorder
  5. Hyperglycaemia
  6. Hypoglycaemia
  7. Neuroleptic malignant syndrome
  8. Pancreatitis
  9. Tardive dyskinesia
  10. Type 2 diabetes mellitus

male:

n/a

Common Detrol La and Stelazine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Diabetes mellitus
  2. Type 2 diabetes mellitus
  3. Diabetic coma
  4. Diabetic ketoacidosis
  5. Extrapyramidal disorder
  6. Hyperglycaemia
  7. Hypoglycaemia
  8. Neuroleptic malignant syndrome
  9. Pancreatitis
  10. Tardive dyskinesia

50-59:

  1. Diabetes mellitus

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Detrol la and Stelazine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Detrol la and Stelazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Detrol la side effects:

Browse all side effects of Detrol la:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Stelazine side effects:

Browse all side effects of Stelazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Detrol la interactions:

Browse all interactions between Detrol la and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Stelazine interactions:

Browse all interactions between Stelazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tolterodine tartrate and trifluoperazine hydrochloride (the active ingredients of Detrol la and Stelazine, respectively), and Detrol la and Stelazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Detrol la and Stelazine.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.